MedTrace Logo

Different Treatment Options Used for Post Covid-19 Syndrome

NCT07722000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-07-28

No results posted yet for this study

Summary

This study aimed to assess functioning during the recovery phase post-COVID-19 and to evaluate symptoms prolonging after COVID-19 infection and how to manage these symptoms.

Conditions

  • COVID-19
  • Post COVID-19 Syndrome
  • Ginkgo Biloba
  • Piracetam

Interventions

DRUG

Ginkgo biloba and Piracetam

Patients who received a combination (Ginkgo biloba and Piracetam).

DRUG

Piracetam

Patients who received piracetam alone.

DRUG

Ginkgo biloba

Patients who received Ginkgo biloba alone.

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07722000 on ClinicalTrials.gov